The Global DuodenoscopesMarket, by Product Type (Flexible Duodenoscopes and Rigid Duodenoscopes),by Application (Diagnostics and Therapeutics), by End User (Hospitals, Clinics,and Ambulatory Centers), and by Region (North America, Latin America, Europe,Asia Pacific, Middle East, and Africa) was valued at US$ 146.6 million in 2019and is projected to exhibit a CAGR of 6.5% over the forecast period (2019 -2027), as highlighted in a new report published by Coherent Market Insights.
Increasing product launches isexpected to propel growth of the global duodenoscopes mamrket
Development of duodenoscopes andendoscopic techniques and tools required for therapeutic intervention ofEndoscopic Retrograde Cholangiopancreatography (ERCP) play a major role in themanagement of pancreaticobiliary diseases. For instance, duodenoscope-assistedcholangiopancreatoscopy has evolved to single-operator platforms withhigh-resolution imaging capabilities including intraductal applications fromdirect visualization and targeted sampling of intraductal neoplasm tolithotripsy of pancreatic duct and bile duct stones.
Manufacturers of duodenoscopedevices are focused on developing innovative products in order to expand theirmarket share. For instance, in 2017, PENTAX Medical launched a high-definitionDuodenoscope (ED34-i10T), which is the first FDA-cleared duodenoscope with adisposable distal cap in the U.S. It is designed to improve the standards oftreatment and safety for both routine and advanced ERCP. The device featuresHigh-Definition imaging and improved clinical control to improve access forcleaning and reprocessing. Several outbreaks of patient infections followingprocedures with duodenoscopes offer potential for manufacturers to developinnovative products which do not transmit infection among patients.
* The sample copy includes: Report Summary, Table ofContents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copyof this report: https://www.coherentmarketinsights.com/insight/request-sample/3779
Increasing prevalence ofgastrointestinal, liver, and pancreatic diseases is expected to drive theduodenoscopes market revenue
Increasing prevalence ofgastrointestinal, liver, and pancreatic diseases is expected to increase demandfor duodenoscopes during the forecast period. For instance, according to theCenter for Disease Control and Prevention report published in 2017, the numberof visits to emergency departments in the U.S. was approximately 8.3 million.
According to the Journal ofGastroenterology 2018 study, Gastrointestinal (GI), liver, and pancreaticdiseases are highly prevalent, costly, and lead to substantial health careutilization in the U.S. In 2018, the total expenditure for GI diseases isapproximately US$ 135.9 Bn in the U.S.
Browse 37 Market Data Tables and29 Figures spread through 185 Pages and in-depth TOC on "DuodenoscopesMarket, by Product Type (Flexible Duodenoscopes and Rigid Duodenoscopes), byApplication (Diagnostics and Therapeutics), by End Use (Hospitals, Clinics, andAmbulatory Centers), and by Region (North America, Latin America, Europe, AsiaPacific, Middle East, and Africa) - Global Forecast to 2027"
Browse ResearchReport: https://www.coherentmarketinsights.com/market-insight/duodenoscopes-market-3779
Key Takeaways of theDuodenoscopes Market:
The global duodenoscopes marketis expected to expand at a CAGR of 6.5% during the forecast period, owing toincreasing incidences of bile duct and pancreatic cancer, tumors, andgastrointestinal diseases. According to the American Institute of CancerResearch reports in 2018 there were approximately 460,000 new cases ofpancreatic cancer globally.
Among product type, the flexibleduodenoscopes segment is expected to generate significant revenue in 2018, dueto ease of usage and high coverage provided by these devices.
Among region, North Americaduodenoscopes market accounted for the highest market share in 2018 due to thehigh prevalence of high GI patient population and availability ofwell-established healthcare facilities coupled with increasing healthcareexpenditure. For instance, in 2019, according to the American Cancer Societyestimates approximately 57,600 individuals in the U.S. will be diagnosed withpancreatic cancer by 2020.
Major players operating in theglobal duodenoscopes market include, Custom Ultrasonics, Inc., ENDOMED,Fujifilm Holdings Corporation, Hoya Corporation, KARL STORZ GmbH & Co. KG.,Olympus Corporation, PENTAX Medical Company, and SonoScape Medical Corp
Buy-Now this researchreport: https://www.coherentmarketinsights.com/insight/buy-now/3779
AboutCoherent Market Insights:
CoherentMarket Insights is a prominent market research and consulting firm offeringaction-ready syndicated research reports, custom market analysis, consultingservices, and competitive analysis through various recommendations related toemerging market trends, technologies, and potential absolute dollaropportunity.
ContactUs:
mailto:sales@coherentmarketinsights.com
U.S.Office:
Name: Mr. Shah
CoherentMarket Insights 1001 4th Ave,
# 3200Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
